Clinical Trial Update: Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update on cytoreductive surgery with HIPEC using lobaplatin for advanced and recurrent epithelial ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Ovarian Cancer

Drugs mentioned

• Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
• Lobaplatin (lobaplatin)

Snippet

Sponsor: Zhongnan Hospital | Conditions: Ovarian Cancer, Ovary Neoplasm | Phase 3 | Status: UNKNOWN